REVIEW article
Front. Cell. Infect. Microbiol.
Sec. Fungal Pathogenesis
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1535246
This article is part of the Research TopicApplications of FungiView all 8 articles
Exploring the health benefits of Ganoderma: Anti-microbial properties and mechanisms of action
Provisionally accepted- 1Qujing Normal University, Qujing, Yunnan, China
- 2Murdoch University, Perth, Western Australia, Australia
- 3Chiang Mai University, Chiang Mai, Thailand
- 4Southwest Forestry University, Kunming, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Ganoderma, a well-known medicinal mushroom, has garnered attention for its broad therapeutic properties, particularly its potent antimicrobial activities. This review focuses on the mechanisms of action and bioactive compounds responsible for the ability of Ganoderma to inhibit various pathogenic microorganisms. The polysaccharides, triterpenoids, proteins, and phenolic compounds in Ganoderma exhibit strong antimicrobial effects by targeting bacterial cell walls, disrupting membrane integrity, and inhibiting key microbial enzymes. These compounds are effective against a wide range of bacteria, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and various fungi. Triterpenoids, specifically, have demonstrated efficacy in modulating immune responses, further enhancing the body's defense mechanisms against infections. Furthermore, the role of Ganoderma in preventing biofilm formation and combating antibiotic-resistant strains highlights its potential as a natural antimicrobial agent. While in vitro and in vivo studies strongly support the antimicrobial properties of Ganoderma, future research should focus on large-scale clinical trials to confirm its efficacy and explore its synergistic effects with conventional antibiotics. Establishing standardized dosages and exploring the molecular pathways of its antimicrobial actions will be key to incorporating Ganoderma into clinical practice for infection control.
Keywords: Antimicrobial activity, biofilm inhibition, pathogenic bacteria, Polysaccharides, Synergistic effects, triterpenoids
Received: 27 Nov 2024; Accepted: 28 May 2025.
Copyright: © 2025 Karunarathna, Patabendige, Promputtha and Hapuarachchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Itthayakorn Promputtha, Chiang Mai University, Chiang Mai, 50200, Thailand
Kalani Hapuarachchi, Southwest Forestry University, Kunming, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.